Be1 Labs
Retatrutide
Retatrutide
Couldn't load pickup availability
Be1Labs Retatrutide 10 mg
⚠️ Important Information
This product is not a food or dietary supplement and is not intended for human consumption. Keep out of reach of children. Store in a cool, dry place away from direct light and moisture. Keep the container tightly closed and store only in the original packaging. Avoid contact during pregnancy and breastfeeding. If you experience any adverse reactions following contact with the substance, consult a healthcare professional.
About Retatrutide
Retatrutide is a novel triple-agonist peptide that simultaneously activates three key metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This unique triple-action mechanism distinguishes it from dual-agonist compounds and positions Retatrutide as one of the most advanced peptides currently under investigation in metabolic and weight management research.
Key Research Highlights
Studies have shown that Retatrutide may:
- Produce significant reductions in body weight through its triple-receptor agonism, surpassing results observed with single- and dual-agonist compounds
- Enhance appetite regulation by acting on multiple satiety and hunger signaling pathways simultaneously
- Improve glycemic control and insulin sensitivity, supporting healthy blood sugar metabolism
- Promote fat oxidation and energy expenditure through glucagon receptor activation
- Reduce hepatic fat content, with potential implications for liver health research
- Support cardiovascular risk factor improvement, including favorable changes in lipid profiles
- Demonstrate sustained metabolic effects due to its optimized pharmacokinetic profile
- Show promising results in clinical trials for both weight management and type 2 diabetes research
Be1Labs Quality Guarantee
Be1Labs Retatrutide 10 mg — laboratory-verified peptide content with 98% purity, confirming the highest standard of product quality.
Share
